Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing

William E. Allen, Han Altae-Tran, James Briggs, +33

Nature Human Behaviour

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE

Isabel Schobert, Lynn Jeanette Savic, Julius Chapiro, +8

European Radiology

Tumor ResponseHepatologyHepatocellular CarcinomaPlatelet-to-lymphocyte RatiosMedicine +6

Socioeconomic and Demographic Disparities in the Use of Telemedicine for Ophthalmic Care during the COVID-19 Pandemic

Evan M. Chen, Joana E. Andoh, Kristen Nwanyanwu

Ophthalmology

Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study

Meera M. Dhodapkar, Xiaoting Shi, Reshma Ramachandran, +3

BMJ

Private Equity in Ophthalmology and Optometry

Evan M. Chen, Jacob T. Cox, Tedi Begaj, +3

Ophthalmology

Ophthalmic SurgeryOphthalmologyOptometryMedicineFinancing +1

Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors

Evan M. Chen, Amanda Quijano, Young-Eun Seo, +9

Biomaterials

NanoparticlesNanomedicineEngineeringSustained Drug DeliveryMedicine +10

COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses

David S. Portney, Ziwei Zhu, Evan M. Chen, +5

Ophthalmology

Neighborhood Deprivation and Adherence to Initial Diabetic Retinopathy Screening

Ramsey Yusuf, Evan M. Chen, Kristen Nwanyanwu, +1

Ophthalmology Retina

Diabetic RetinopathyDiabetes ManagementOphthalmologyDiabetesNeighborhood Deprivation +1

Ophthalmic Medication Expenditures and Out-of-Pocket Spending

Evan M. Chen, Ninani Kombo, Christopher C. Teng, +3

Ophthalmology

Health EconomicsHealth PolicyOphthalmologyHealth InsuranceOphthalmic Medication Expenditures +5

Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas

Amanda R. King, Christopher D. Corso, Evan M. Chen, +6

Molecular Cancer Therapeutics